“预防接种异常反应”定义辨析

“预防接种异常反应”定义辨析

彭向东,胡晓江

北京师范大学社会发展与公共政策学院,北京师范大学社会发展与公共政策学院

收稿日期:2016-02-25 修回日期:2016-08-14 出版日期:2016-08-25 发布日期:2016-08-25
基金资助:
国家自然科学基金项目（面上项目，重点项目，重大项目）

Critical Analysis on the Definitions of Adverse Events Following Immunization in China

彭向东 and 胡晓江

School of Social Development and Public Policy,Beijing Normal University,Beijing,100875,

Received:2016-02-25 Revised:2016-08-14 Online:2016-08-25 Published:2016-08-25
Supported by:
The National Natural Science Foundation of China (General Program, Key Program, Major Research Plan)

摘要/Abstract

摘要： 虽然预防接种异常反应发生的概率极低，但一旦发生,却常常产生较大的负面社会影响，成为社会普遍关心的问题。本文对有关预防接种负性事件的几个重要定义进行了辨析，包括世界卫生组织(WHO)的定义，我国 “预防接种异常反应”法律定义和 “疑似预防接种异常反应”监测定义。发现我国疑似预防接种异常反应中文名称与英文译名不符，名词之间容易混淆。预防接种异常反应的定义造成在寻求证据和因果关系判定方面存在实际操作困难，需要修改法律定义以放宽证据把握尺度，并借鉴美国“疫苗伤害表”简化因果关系判定标准。建议在更多实证研究获取证据基础上，采用WHO预防接种不良事件概念和定义，并采用无过错责任补偿原则替代《疫苗流通和预防接种管理条例》中对预防接种异常反应的严格法律定义。

Abstract: "Adverse events following immunization"(AEFI) refers to extremely rare events associated with immunization. Despite their rarity, AEFI events in China often have large negative social consequences. This research investigates three definitions of AEFI: the one adopted by the WHO, the one adopted by the Chinese juridical system, and the one adopted by the Chinese disease surveillance system. It is found that the Chinese term Suspected Rare Vaccine Reactions and its English translation (AEFI) do not match. Further confusion is created by the disparities among Chinese terms, WHO term of AEFI and its Chinese translation. The legal definition of AEFI (Rare Vaccine Reactions), which is the standard used in compensation cases in China, is narrower and stricter than the no-fault compensation principle adopted by many countries. Chinese legal definition of AEFI causes operational difficulties in gathering evidence and determining causality. It is suggested that China should adopt the WHO recommended AEFI definition in surveillance, amend the legal definitionsto lessen the requirement for evidence, adopt the “vaccine injury table” method to simplify the causality criteria, and adopt the no fault compensation principle in legal cases,,so that more equitable compensation outcomes may be created.

彭向东,胡晓江. “预防接种异常反应”定义辨析[J]. .

彭向东 and 胡晓江. Critical Analysis on the Definitions of Adverse Events Following Immunization in China[J]. .

参考文献

[1] 王宇. 中国乙型肝炎疫苗接种及其成效[J]. 中国疫苗和免疫, 2014(02):97-99.
[2] 国务院. 疫苗流通和预防接种管理条例[EB/OL]. [1月15日]. http://www.gov.cn/zwgk/2005-05/23/content_275.htm.
[3] 李克莉. 预防接种后不良事件个案因果关联评估法则[J]. 中国疫苗和免疫, 2013(02):184-188.
[4] Duclos P. A global perspective on vaccine safety[J]. Vaccine, 2004,22(15-16):2059-2063.
[5] WHO. Global Vaccine Safety Blueprint[M/OL]. [2013年3月23日]. https://extranet.who.int/iris/restricted/bitstream/10665/70919/1/WHO_IVB_12.07_eng.pdf.
[6] 卫生部新闻办公室. 《预防接种工作规范》出台[EB/OL]. [2012-11-12]. http://www.moh.gov.cn/publicfiles/business/htmlfiles/wsb/pzcjd/200804/20990.htm.
[7] 卫生部. 全国疑似预防接种异常反应监测方案[EB/OL]. [1月16日]. http://www.moh.gov.cn/publicfiles/business/htmlfiles/mohjbyfkzj/s8428/201010/49480.htm.
[8] 徐喜荣. 预防接种异常反应补偿制度研究[J]. 中国卫生事业管理, 2013(03):169-171.
[9] 姚开虎, 杨永弘. 疑似预防接种异常反应及其与预防接种的因果关系评估[J]. 中国当代儿科杂志, 2014(01):1-4.
[10] 叶英红, 凌晓萍, 吴平兰. 预防接种异常反应表现分析与护理防范[J]. 全科护理, 2014(34):3231-3232.
[11] Liu D, Wu W, Li K, et al. Surveillance of adverse events following immunization in China: Past, present, and future[J]. Vaccine, 2015.
[12] Liang X F, Li L, Liu D W, et al. Safety of influenza A (H1N1) vaccine in postmarketing surveillance in China[J]. N Engl J Med, 2011,364(7):638-647.
[13] 尚鹏辉, 刘大卫, 刁琳琪, 等. 预防接种异常反应补偿机制态度调查分析[J]. 中国计划免疫, 2007(6).
[14] 尚鹏辉, 梁晓峰. 国内外关于预防接种异常反应的经济补偿[J]. 中国计划免疫, 2007,13(5):487-490.
[15] 常利民, 刘大卫, 王华庆. 国内外疑似预防接种异常反应监测报告和诊断标准的研究现状[J]. 中国疫苗和免疫, 2012(05):465-468.
[16] 徐若辉, 蔡润, 富继业, 等. 北京市海淀区2012年疑似预防接种异常反应监测分析[J]. 实用预防医学, 2014(07):814-817.
[17] 顾凯辰, 孙美平, 苗良. 国内外疑似预防接种不良事件监测进展[J]. 中国执业药师, 2012(09):10-14.
[18] 金岳霖. 形式逻辑[M]. 2. 人民出版社, 2006.
[19] 杜仪方. 日本预防接种事件中的因果关系——以判决为中心的考察[J]. 华东政法大学学报, 2014(01):57-71.
[20] Halsey N A, Edwards K M, Dekker C L, et al. Algorithm to assess causality after individual adverse events following immunizations[J]. Vaccine, 2012,30(39):5791-5798.
[21] 徐若辉, 蔡润, 富继业, 等. 2009-2013年北京市海淀区预防接种异常反应监测[J]. 首都公共卫生, 2014(06):269-273.
[22] 谢广中. 预防接种与偶合症[J]. 上海预防医学, 2008,20(5):260-262.
[23] HHS F A C. Vaccine Adverse Event Reporting System Brochure[Z]. 2013.
[24] Vaccine safety and adverse events following immunisation: the green book, chapter 8 - Publications - Inside Government - GOV.UK[EB/OL]. [2013/3/30]. https://www.gov.uk/government/publications/vaccine-safety-and-adverse-events-following-immunisation-the-green-book-chapter-8.
[25] Reporting Adverse Events Following Immunization (AEFI) in Canada - Public Health Agency of Canada[EB/OL]. [2013/3/30]. http://www.phac-aspc.gc.ca/im/aefi-essi_guide/index-eng.php.
[26] Mahajan D, Cook J, Dey A, et al. Annual report: surveillance of adverse events following immunisation in Australia, 2011[J]. Commun Dis Intell, 2012,36(4):E315-E332.
[27] 吕群蓉. 论我国强制医疗责任保险制度的构建——以无过错补偿责任为分析进路[J]. 法学评论, 2014(04):112-118.
[28] 任华玉, 息悦, 李中华, 等. 关于完善我国医疗风险分担机制的研究[J]. 中国卫生经济, 2014(09):39-41.
[29] 曾见, 夏民, 彭加茂, 等. 无过错医疗损害救助制度在我国的首次试验——《镇江市无过错医疗损害救助办法》的主要内容与评价[J]. 中国卫生事业管理, 2014(12):919-921.
[30] 镇江市人民代表大会常务委员会. 镇江市人民政府关于印发《镇江市无过错医疗损害救助办法》的通知[EB/OL]. [2015-05-22]. http://www.zjrdw.gov.cn/doc_show.jsp?id=11647.
[31] 刘洪华. 过错在现代侵权法上的重新定位[J]. 云南大学学报(法学版), 2015(01):26-30.
[32] 刘士国. 论无过错责任[J]. 法学研究, 1994(05):37-42.
[33] 康琪, 梁萍, 宋民宪. 药品不良反应定义中“正常”的界定[J]. 中药与临床, 2013(01):50-52.
[34] 耿东升. 对药品不良反应定义及其分类的商榷[J]. 西北药学杂志, 2011(01):59-61.
[35] 柴月. 我国预防接种异常反应救济制度之完善——以美国儿童疫苗伤害救济制度的改革为视角[J]. 司法改革论评, 2014(02):329-338.
[36] 齐晓霞. 美国疫苗伤害补偿计划及其对我国的启示[J]. 行政与法, 2011(3):90-92.
[37] Looker C, Kelly H. No-fault compensation following adverse events attributed to vaccination: a review of international programmes[J]. Bull World Health Organ, 2011,89(5):371-378.